PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Globus Medical, Inc. (GMED)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS3795772082
CUSIP379577208
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$6.84B
EPS$1.07
PE Ratio47.24
PEG Ratio1.75
Revenue (TTM)$1.57B
Gross Profit (TTM)$759.12M
EBITDA (TTM)$418.24M
Year Range$43.39 - $62.88
Target Price$61.46
Short %6.70%
Short Ratio7.36

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Globus Medical, Inc.

Popular comparisons: GMED vs. VOO, GMED vs. AMC, GMED vs. SYK, GMED vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Globus Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


220.00%240.00%260.00%280.00%300.00%320.00%December2024FebruaryMarchAprilMay
284.81%
268.64%
GMED (Globus Medical, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Globus Medical, Inc. had a return of -2.51% year-to-date (YTD) and -8.20% in the last 12 months. Over the past 10 years, Globus Medical, Inc. had an annualized return of 7.82%, while the S&P 500 had an annualized return of 10.64%, indicating that Globus Medical, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-2.51%7.50%
1 month-0.75%-1.61%
6 months10.56%17.65%
1 year-8.20%26.26%
5 years (annualized)3.71%11.73%
10 years (annualized)7.82%10.64%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-0.94%2.27%-0.65%-7.18%
2023-7.94%-1.73%18.63%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of GMED is 32, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of GMED is 3232
Globus Medical, Inc.(GMED)
The Sharpe Ratio Rank of GMED is 3131Sharpe Ratio Rank
The Sortino Ratio Rank of GMED is 2727Sortino Ratio Rank
The Omega Ratio Rank of GMED is 2828Omega Ratio Rank
The Calmar Ratio Rank of GMED is 3737Calmar Ratio Rank
The Martin Ratio Rank of GMED is 3535Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


GMED
Sharpe ratio
The chart of Sharpe ratio for GMED, currently valued at -0.32, compared to the broader market-2.00-1.000.001.002.003.004.00-0.32
Sortino ratio
The chart of Sortino ratio for GMED, currently valued at -0.27, compared to the broader market-4.00-2.000.002.004.006.00-0.27
Omega ratio
The chart of Omega ratio for GMED, currently valued at 0.97, compared to the broader market0.501.001.500.97
Calmar ratio
The chart of Calmar ratio for GMED, currently valued at -0.18, compared to the broader market0.002.004.006.00-0.18
Martin ratio
The chart of Martin ratio for GMED, currently valued at -0.55, compared to the broader market-10.000.0010.0020.0030.00-0.55
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.17, compared to the broader market-2.00-1.000.001.002.003.004.002.17
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.11, compared to the broader market-4.00-2.000.002.004.006.003.11
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.65, compared to the broader market0.002.004.006.001.65
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.41, compared to the broader market-10.000.0010.0020.0030.008.41

Sharpe Ratio

The current Globus Medical, Inc. Sharpe ratio is -0.32. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Globus Medical, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.32
2.17
GMED (Globus Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Globus Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-38.20%
-2.41%
GMED (Globus Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Globus Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Globus Medical, Inc. was 47.91%, occurring on Nov 13, 2023. The portfolio has not yet recovered.

The current Globus Medical, Inc. drawdown is 38.20%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-47.91%Sep 9, 2021549Nov 13, 2023
-44.69%Oct 3, 201259Dec 28, 2012212Oct 31, 2013271
-41.08%Dec 20, 201958Mar 16, 2020177Nov 24, 2020235
-33.7%Nov 9, 201836Jan 3, 2019238Dec 12, 2019274
-32.69%Apr 3, 2014104Aug 29, 2014223Jul 21, 2015327

Volatility

Volatility Chart

The current Globus Medical, Inc. volatility is 6.22%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%December2024FebruaryMarchAprilMay
6.22%
4.10%
GMED (Globus Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Globus Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items